Abstract:Purpose of review: The goals of this review are two folds: (1) to describe the recent understandings on the roles of calcitonin gene-related peptide-α (CGRP) in bone homeostasis and the underlying mechanisms of related neuronal regulation and (2) to propose innovative CGRP-modulated approaches for enhancing bone regeneration in challenging bone disorders. Recent findings: CGRP is predominantly produced by the densely distributed sensory neuronal fibers in bone, declining with age. Under mechanical and biochemical stimulations, CGRP releases and exerts either physiological or pathophysiological roles. CGRP at physiological level orchestrates the communications of bone cells with cells of other lineages, affecting not only osteogenesis, osteoclastogenesis, and adipogenesis but also angiogenesis, demonstrating with pronounced anabolic effect, thus is essential for maintaining bone homeostasis, with tuned nerve-vessel-bone network. In addition, its effects on immunity and cell recruitment are also crucial for bone fracture healing. Binding to the G protein-coupled receptor composited by calcitonin receptor-like receptor (CRLR) and receptor activity modifying protein 1 (RAMP1) on cellular surface, CGRP triggers various intracellular signaling cascades involving cyclic adenosine monophosphate (cAMP) and cAMP response element-binding protein (CREB). Peaking at early stage post-fracture, CGRP promotes bone formation, displaying with larger callus. Then CGRP gradually decreases over time, allowing normal or physiological bone remodeling. By elevating CGRP at early stage, low-intensity pulsed ultrasound (LIPUS), electrical stimulation, and magnesium-based bio-mineral products may promisingly accelerate bone regeneration experimentally in medical conditions like osteoporosis, osteoporotic fracture, and spine fusion. Excess CGRP expression is commonly observed in pathological conditions including cancer metastatic lesions in bone and fracture delayed- or non-healing, resulting in persistent chronic pain. To date, these discoveries have largely been limited to animal models. Clinical applications are highly desirable. Compelling evidence show the anabolic effects of CGRP on bone in animals. However, further validation on the role of CGRP and the underlying mechanisms in human skeletons is required. It remains unclear if it is type H vessel connecting neuronal CGRP to osteogenesis, and if there is only specific rather than all osteoprogenitors responsible to CGRP. Clear priority should be put to eliminate these knowledge gaps by integrating with high-resolution 3D imaging of transparent bulk bone and single-cell RNA-sequencing. Last but not the least, given that small molecule antagonists such as BIBN4096BS can block the beneficial effects of CGRP on bone, concerns on the potential side effects of humanized CGRP-neutralizing antibodies when systemically administrated to treat migraine in clinics are arising.

CGRP gene-modified rBMSCs show better osteogenic differentiation capacity in vitro

Calcitonin gene-related peptide enhances osteogenic differentiation and recruitment of bone marrow mesenchymal stem cells in rats.

Effect of CGRP-Adenoviral Vector Transduction on the Osteoblastic Differentiation of Rat Adipose-Derived Stem Cells

Calcitonin Gene-Related Peptide Induces Proliferation and Monocyte Chemoattractant Protein-1 Expression Via Extracellular Signal-Regulated Kinase Activation in Rat Osteoblasts

αCGRP Regulates Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Through ERK1/2 and p38 MAPK Signaling Pathways

Experimental study of osteogenic differentiation of precartilaginous stem cells induced by calcitonin gene-re-lated peptide

Neural Peptide α-CGRP Coregulated Angiogenesis and Osteogenesis via Promoting the Cross-Talk between Mesenchymal Stem Cells and Endothelial Cells

Effect of Calcitonin Gene-Related Peptide on Bone Marrow-Derived Mesenchymal Stem Cells and Osteogenic Differentiation in Rats

Enhanced proliferation and differentiation effects of a CGRP- and Sr-enriched calcium phosphate cement on bone mesenchymal stem cells.

Effect Of Calcitonin Gene-Related Peptide On The Neurogenesis Of Rat Adipose-Derived Stem Cells In Vitro

Calcitonin gene-related peptide promotes the expression of osteoblastic genes and activates the WNT signal transduction pathway in bone marrow stromal stem cells.

The effect of calcitonin gene-related peptide on osteoclast differentiation by rat bone marrow macrophages in vitro

The Effects of Calcitonin Gene-Related Peptide on Bone Homeostasis and Regeneration

Calcitonin Gene-Related Peptide Promotes Proliferation and Differentiation of MG-63 Cells Via Extracellular Signal-Regulated Kinase Pathway in Vitro

Gelatin microspheres containing calcitonin gene-related peptide or substance P repair bone defects in osteoporotic rabbits

Enhanced Osteogenic Activity of Mesenchymal Stem Cells and Co-Modified BMP-2 and Bfgf Genes.

Effect of lentiviral vector overexpression α-calcitonin gene-related peptide on titanium implant osseointegration in α-CGRP-deficient mice

CGRP Regulates the Age-Related Switch Between Osteoblast and Adipocyte Differentiation (vol 9, 675503, 2021)

Effect of C-type natriuretic peptide gene transfection on the chondrogenic differentiation of bone marrow mesenchymal stem cells

Activation of CGRP receptor–mediated signaling promotes tendon-bone healing

Effect of Calcitonin Gene-Related Peptide on RUNX2 Expression in Primary Rat Osteoblasts